In bladder cancer, FSIP1 knockdown inhibited the PI3K/AKT signaling pathway in vitro and in vivo, thereby suppressing the malignant behavior of bladder cancer cells. The gene discussed is AKT1; the disease is urinary bladder carcinoma.